←back to thread

236 points Eumenes | 1 comments | | HN request time: 0.212s | source
Show context
cm2187 ◴[] No.42199591[source]
> emerging research showing that up to 40 per cent of the weight lost by people using weight-loss drugs is actually muscle

That's the sort of headlines that smells like bullshit to me.

My understand of those drugs is that they don't actually make you lose weight, they just cut your appetite so you can follow a diet to lose weight without hunger hammering at the door. So to start with, if that's the case, all they are observing is the effect of a diet. Not sure the diet drug has much to do with it.

Then I went from 133kg to 88kg with these diet drugs. Even though I exercised every day, I am sure I also lost some muscle mass as well, just because I don't have to carry 45kg every time I make a move anymore. Seems logical and would probably be concerned if it was any other way.

replies(10): >>42199621 #>>42199630 #>>42199644 #>>42199659 #>>42199679 #>>42199705 #>>42199766 #>>42199811 #>>42199873 #>>42200454 #
adrian_b ◴[] No.42199705[source]
See the actual research article:

https://www.sciencedirect.com/science/article/pii/S2452302X2...

This study on mice was suggested by a previous publication:

https://www.thelancet.com/journals/landia/article/PIIS2213-8...

where it had been noticed that in humans "the muscle loss with these medications (as indicated by decreases in fat-free mass [FFM]) ranges from 25% to 39% of the total weight lost over 36–72 weeks", in comparison with muscle loss of only 10% to 30% when the weight is lost just by eating less, without semaglutide.

So with semaglutide, a larger fraction of the weight loss affects muscles than when the same weight is lost by traditional means.

While for other muscles the loss of mass may not be so important, the fact that at least in mice the loss also affects the heart is worrisome and it certainly warrants further studies.

replies(1): >>42199758 #
1. petesergeant ◴[] No.42199758[source]
> Studies suggest muscle loss with these medications (as indicated by decreases in fat-free mass [FFM]) ranges from 25% to 39% of the total weight lost over 36–72 weeks. This substantial muscle loss can be largely attributed to the magnitude of weight loss, rather than by an independent effect of GLP-1 receptor agonists, although this hypothesis must be tested. By comparison, non-pharmacological caloric restriction studies with smaller magnitudes of weight loss result in 10–30% FFM losses

Emphasis my own. In short: no evidence this is anything other than due to rapid weight-loss.